HER2 or EGFR Expressing Advanced Solid Malignancies
1 clinical trials · Condition
◉ Watch HER2 or EGFR Expressing Advanced Solid Malignancies
| Record | Firm | Date |
|---|---|---|
| MAD Refractory: Solid Tumor QD w/o Break (NCT00207012) | Bristol-Myers Squibb | 2004-05-01 |
Track HER2 or EGFR Expressing Advanced Solid Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.